Press Releases from BIOCAD (1 total)
BIOCAD Enters European Market
The largest Russian biotechnology company BIOCAD plans to enter the European market with oncological and autoimmune medicines. So far, there are seven molecules in the European portfolio of BIOCAD. This are innovative and biosimilar products, which could be used in treatment of melanoma, breast, stomach, kidney and lung cancer, rheumatoid arthritis, psoriasis and multiple sclerosis.
BIOCAD presents its latest developments at the CPhI exhibition in Frankfurt on October 24-26, 2017. The…
